Status:
COMPLETED
Singing for Health: Improving Experiences of Lung Disease (SHIELD Trial)
Lead Sponsor:
Imperial College London
Conditions:
COPD
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
A randomised clinical trial to assess the impact of group singing on health for people with chronic obstructive pulmonary disease (COPD).
Detailed Description
Singing for lung health (SLH) is a novel approach intended to improve the health status of people with respiratory disease. In group sessions, a trained singing leader teaches vocal techniques, which ...
Eligibility Criteria
Inclusion
- Adults with stable COPD
Exclusion
- Pulmonary rehabilitation less than 4 months ago
- Unable to take part in singing sessions due to comorbidity (e.g. life limiting illness, cognitive impairment)
- Previous participation in SLH classes
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04034212
Start Date
October 1 2019
End Date
February 15 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart and Lung Institute, Imperial College London
London, United Kingdom